EY is proud to be a sponsor for the Medtech Strategist Innovation Summit, to be held from 26 to 28 April in Dublin. The conference will offer a deep dive on the big issues and trends driving the medical device industry.
John Babitt, Partner, EY
John Babitt is the EY MedTech leader for the Americas and is also the Life Sciences Leader for Financial and Accounting Transaction Advisory. John has over 20 years of experience, all in the healthcare industry, and originally joined E&Y in 1995. John’s corporate clients include but not limited to: Medtronic, Johnson & Johnson (including DePuy), Fresenius, GE Healthcare and Bayer, and significant PE clients including, Apax, Warburg Pincus, Avista Capital, Linden and Altaris.
Topic: Keynote: Medtech 2022……where do we go after the pandemic?
Date & Time: 27 April, 9:25-10:05am
Colin Doolin, Associate Partner, EY
Colin Doolin is based in EY Dublin and is an Associate Partner in the firm’s Global Trade Team, a unique practice which is solely dedicated to advising the firm’s key MNC clients on indirect tax issues affecting their business across the World.
He has extensive Customs and International Trade experience and has worked with a large number of clients in a wide range of industries providing expertise in implementing cost saving programs and assisting with integration and compliance projects.
Topic: The New Post Pandemic Supply Chain Issues for Medtech
Date & Time: 27 April, 11:30am-12:00pm
Gary Curran, Senior Manager, EY
Gary Curran is a Senior Manager in EY’s Business Consulting services competency with a specific focus on Supply Chain Global Trade & Tax.
Gary has a wide range of experience in process design and development, along with supply chain system implementations, improvement and Operating Model optimization across multiple industries, including Construction, Mining, Healthcare and Life Sciences, and Software.
Gary has completed postgraduate work in Business Administration at NUIG, Ireland and Business Studies at UoP, USA.